Literature DB >> 9038739

Association between Helicobacter pylori infection and serum pepsinogen concentrations in gastroduodenal disease.

K Matsumoto1, N Konishi, M Ohshima, Y Hiasa, E Kimura, T Samori.   

Abstract

AIM: To investigate the association between Helicobacter pylori infection and serum pepsinogen (PG) 1 and 2 concentrations in various gastroduodenal diseases.
METHODS: Serum PG1 and 2 concentrations and antibodies to H pylori were measured by enzyme linked immunosorbent assay (ELISA); gastric mucosal pH was assessed and urease activity in biopsy tissue was determined. A comparison of the ELISA and urease test results permitted division of the cases into positive, false positive, false negative and negative categories for control, gastritis, and ulcer groups.
RESULTS: The gastric mucosal pH and serum PG2 in cases positive for H pylori were significantly increased in ulcer and gastritis cases compared with H pylori negative cases. Similar tendencies were observed for the false positive and false negative categories.
CONCLUSIONS: A positive ELISA reaction for antibodies and an increased serum PG2 concentration are reliable indicators of H pylori infection.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 9038739      PMCID: PMC499650          DOI: 10.1136/jcp.49.12.1005

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  32 in total

1.  Campylobacter pyloridis and gastritis.

Authors:  B J Marshall
Journal:  J Infect Dis       Date:  1986-04       Impact factor: 5.226

2.  Unidentified curved bacilli on gastric epithelium in active chronic gastritis.

Authors:  J R Warren; B Marshall
Journal:  Lancet       Date:  1983-06-04       Impact factor: 79.321

3.  Multifocal atrial tachycardia: a toxic effect of theophylline.

Authors:  J H Levine; J R Michael; T Guarnieri
Journal:  Lancet       Date:  1985-01-05       Impact factor: 79.321

4.  Pepsinogens I and II: purification from gastric mucosa and radioimmunoassay in serum.

Authors:  I M Samloff
Journal:  Gastroenterology       Date:  1982-01       Impact factor: 22.682

5.  Relationships among serum pepsinogen I, serum pepsinogen II, and gastric mucosal histology. A study in relatives of patients with pernicious anemia.

Authors:  I M Samloff; K Varis; T Ihamaki; M Siurala; J I Rotter
Journal:  Gastroenterology       Date:  1982-07       Impact factor: 22.682

6.  Serum pepsinogens I and II and gastric mucosal histology after partial gastrectomy.

Authors:  P Sipponen; I M Samloff; M Saukkonen; K Varis
Journal:  Gut       Date:  1985-11       Impact factor: 23.059

7.  Detection of Campylobacter pyloridis in patients with antrum gastritis and peptic ulcers by culture, complement fixation test, and immunoblot.

Authors:  H von Wulffen; J Heesemann; G H Bützow; T Löning; R Laufs
Journal:  J Clin Microbiol       Date:  1986-11       Impact factor: 5.948

8.  Antibody to the gastric campylobacter-like organism ("Campylobacter pyloridis")--clinical correlations and distribution in the normal population.

Authors:  D M Jones; J Eldridge; A J Fox; P Sethi; P J Whorwell
Journal:  J Med Microbiol       Date:  1986-08       Impact factor: 2.472

9.  Enzyme-linked immunosorbent assay for Campylobacter pyloridis: correlation with presence of C. pyloridis in the gastric mucosa.

Authors:  C S Goodwin; E Blincow; G Peterson; C Sanderson; W Cheng; B Marshall; J R Warren; R McCulloch
Journal:  J Infect Dis       Date:  1987-03       Impact factor: 5.226

10.  Systemic and local antibody responses to gastric Campylobacter pyloridis in non-ulcer dyspepsia.

Authors:  B J Rathbone; J I Wyatt; B W Worsley; S E Shires; L K Trejdosiewicz; R V Heatley; M S Losowsky
Journal:  Gut       Date:  1986-06       Impact factor: 23.059

View more
  1 in total

1.  Biomarkers in various types of atrophic gastritis and their diagnostic usefulness.

Authors:  Kazimierz Rembiasz; Peter C Konturek; Danuta Karcz; Stanislaw J Konturek; Władysław Ochmanski; Wladyslaw Bielanski; Andrzej Budzynski; Jerzy Stachura
Journal:  Dig Dis Sci       Date:  2005-03       Impact factor: 3.199

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.